Olanzapine

7 Drugs classified under this active ingredient

Atypical Antipsychotic. Olanzapine 5 mg, 10 mg.
ORODISPERS. TABS: 28 x 5 mg, 10 mg. 1
x dly bef./aft. meal. Schizophren:
Initial: 5-10 mg. Target dose: 10 mg
dly. Further adjust. at intervals of not
less than 1 wk. Maint: 10-20 mg dly.
Bipolar disord: Initial: 10-15 mg 1 x dly.
Prevent. recurr. in bipolar disord:
Initial: 10 mg dly. Safety of doses
above 20 mg dly not evaluat.
Acute/maint. tmt schizophrenia. Shortterm
tmt acute manic episodes associat.
with bipolar I disord, prevent. recurr.
bipolar disord. Combinat. with lithium or
valproat for short-term tmt acute manic
episodes assoc. with bipolar I disord.
C/I: Known hypersens., known risk of
narrow-angle glaucoma, lact.,
dementia-related psychoses.

Atypical Antipsychotic. Olanzapine 5, 7.5, 10 mg.
F.C. TABS: 28 x 5 mg, 10 mg, 15 mg;
56 x 7.5 mg. 1 x dly bef./aft. meal. Schizophren: Initial: 5-10 mg. Target dose: 10 mg dly. Further adjust. at intervals of not less than 1 wk. Maint: 10-20 mg dly. Bipolar disord: Initial: 10-15 mg 1 x dly. Prevent. recurr. in bipolar disord: Initial: 10 mg dly. Safety of doses
above 20 mg dly not evaluat.
Acute/maint. tmt schizophrenia. Shortterm
tmt acute manic episodes associat.
with bipolar I disord, prevent. recurr.
bipolar disord. Combinat. with lithium or
valproat for short-term tmt acute manic
episodes assoc. with bipolar I disord.
C/I: Known hypersens., known risk of
narrow-angle glaucoma, lact.,
dementia-related psychoses.

Atypical Antipsychotic. Olanzapine 5, 7.5, 10 mg.
F.C. TABS: 30 x 5 m, 10 mg, 60 x 7.5 mg.
ORODISPERS. TABS (OTD).: 30 × 5, 10 mg.
Initial, maint: 10 mg dly. Adjust in range: 5-20 mg dly. See lit.
Schizophren., manifest. psychot. disord., short-term tmt. acute manic episodes assoc. with Bipolar I Disord. Prevent. recur. manic episodes in pts. with Bipolar Disorder who have responded to olanzapine tmt.
C/I: Hypersens., known risk narrow-angle glaucoma.

Atypical Antipsychotic. Olanzapine 210 mg, 450 mg.
KIT: Vial (pwdr. for susp. for I.M.): 1 +
diluent, syringe, incl. needle). Admin.
every 2-4 wks. by deep I.M. gluteal inj.
Estab. oral olanzapine tolerab. prior to
initiat. tmt.
Schizophrenia.
C/I: Hypersens., narrow-angle glaucoma.

Atypical Antipsychotic. Olanzapine 5, 7.5, 10 mg.
TABS: 28 x 5 mg, 7.5 mg, 10 mg; 56 x
7.5 mg. Initial and maint: 10 mg dly.
Adjust in range of 5-20 mg dly. See lit.
Schizophren., manifest. psychot. disord.,
short-term tmt. acute manic episodes
assoc. with Bipolar I Disord. Prevent.
recur. manic episodes in pts. with Bipolar
Disorder who have responded to
olanzapine tmt.
VIAL: 1 x 10 mg/vial. 10 mg as single
I.M. inject. Lower dose (5 mg or 7.5 mg)
depend. on individ. clin. status. If reqd.
2nd inject: 5-10 mg depend. on individ.
clin. status. Max. dly dose (incl. oral
dose): 20 mg - not more than 3 injects.
in 24 hrs.
Rapid control agitat., disturb. behav. in
schizophren. when oral ther. not
appropriate.
C/I: Hypersens., known risk narrowangle
glaucoma.

Atypical Antipsychotic. Olanzapine 10 mg / 2 ml.
VIAL: 1 x 10 mg/vial. 10 mg as single
I.M. inject. Lower dose (5 mg or 7.5 mg)
depend. on individ. clin. status. If reqd.
2nd inject: 5-10 mg depend. on individ.
clin. status. Max. dly dose (incl. oral
dose): 20 mg - not more than 3 injects.
in 24 hrs.
Rapid control agitat., disturb. behav. in
schizophren. when oral ther. not
appropriate.
C/I: Hypersens., known risk narrowangle
glaucoma.